Fig 1.
CONSORT Flowchart Participant Flow and Recruitment.
Table 1.
Clinical characteristics of the study population.
Fig 2.
Comparison of individual changes of FMD before and after administration of liraglutide and glargine.
White circles are mean ± SD.
Table 2.
Comparison of changes in %FMD before and after treatment in each group.
Table 3.
Comparison of the effects on endothelial function and clinical and biochemical parameters between liraglutide and glargine.
Table 4.
Relationship between the changes in %FMD and other metabolic parameters pre- and post-treatment with liraglutide or glargine.